Related Experiment Video

Updated: Feb 12, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.7K

Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates

Xing-Hua Xiao1,2, Lin-Chen Lv3,4, Jing Duan5,6

  • 1Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China. xiaoxinghua1988@sohu.com.

Molecules (Basel, Switzerland)
|March 30, 2018
PubMed

Insights

Targeting Cdc42, a key regulator of cell growth and metastasis, offers new cancer treatment strategies. Inhibiting its abnormal expression with small molecules and miRNAs shows promise in slowing cancer spread and improving therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastatic cancer remains a leading cause of cancer-related mortality, necessitating novel therapeutic strategies.
  • Cdc42, a Rho GTPase, regulates critical cellular processes including proliferation, migration, and invasion, all vital in tumor formation.
  • Abnormal Cdc42 expression is implicated in numerous human cancers, driving neoplastic growth and metastasis.

Purpose of the Study:

  • To review newly identified Cdc42 regulation mechanisms and related signaling pathways.
  • To explore novel therapeutic approaches targeting Cdc42 overexpression in cancer.
  • To highlight the potential of small molecules and microRNAs (miRNAs) in cancer treatment.

Main Methods:

  • Literature review of recent studies on Cdc42 function and regulation in cancer.
  • Analysis of signaling pathways influenced by Cdc42.
  • Examination of emerging therapeutic strategies involving small molecules and miRNAs targeting Cdc42.

Main Results:

  • Cdc42 acts as a central signaling hub, regulating multiple pathways crucial for cancer progression.
  • Abnormal Cdc42 expression is a common feature in human cancers, promoting tumor growth and metastasis.
  • Small molecules and miRNAs targeting Cdc42 have demonstrated efficacy in preclinical cancer models.

Conclusions:

  • Inhibiting aberrant Cdc42 signaling presents a promising avenue for developing new anti-cancer drugs.
  • Targeted therapies using small molecules and miRNAs could significantly impede cancer metastasis.
  • Further research into Cdc42 pathways may yield improved cancer control strategies and novel antineoplastic agents.
Keywords:
Cdc42Cdc42-related signaling pathwayscancer therapymiRNAssmall molecules

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K